Literature DB >> 19002450

The spleen in the sickling disorders: an update.

Rana Khatib1, Raja Rabah, Sharada A Sarnaik.   

Abstract

In early life, patients with sickle cell disease (SCD) can have acute, life-threatening emergencies related to splenic hypofunction (overwhelming bacterial sepsis), as well as anemic crises from acute splenic sequestration because of sudden pooling of blood in the spleen. The landmark penicillin prophylaxis study in 1985 showed a remarkable decrease in mortality from sepsis in young children with SCD who were treated with oral penicillin prophylaxis compared to placebo. Since that study, newborns are screened for SCD and placed on oral penicillin prophylaxis in nearly all of the United States, as well as in other countries where the disease is highly prevalent. The previously described permanent, complete and nearly universal "autosplenectomy" emerging by late childhood or early adulthood is now challenged by recent findings of reversibility of splenic dysfunction by the antisickling drug hydroxyurea or by successful allogeneic stem cell transplantation, even in older patients. Imaging techniques for hypofunction of the spleen are the most commonly used modalities to guide the clinician in decisions regarding medical or surgical management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002450     DOI: 10.1007/s00247-008-1049-9

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  38 in total

1.  Improved T2* assessment in liver iron overload by magnetic resonance imaging.

Authors:  Vincenzo Positano; Benedetta Salani; Alessia Pepe; Maria Filomena Santarelli; Daniele De Marchi; Anna Ramazzotti; Brunella Favilli; Eliana Cracolici; Massimo Midiri; Paolo Cianciulli; Massimo Lombardi; Luigi Landini
Journal:  Magn Reson Imaging       Date:  2008-07-30       Impact factor: 2.546

2.  Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy.

Authors:  N F Olivieri; E P Vichinsky
Journal:  J Pediatr Hematol Oncol       Date:  1998 Jan-Feb       Impact factor: 1.289

3.  Management of acute splenic sequestration crisis in sickle cell disease.

Authors:  R Grover; D L Wethers
Journal:  J Assoc Acad Minor Phys       Date:  1990

4.  A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report.

Authors:  J T Casper; S Koethe; G E Rodey; L G Thatcher
Journal:  Blood       Date:  1976-02       Impact factor: 22.113

5.  First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration.

Authors:  S Claster; E Vichinsky
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

6.  Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.

Authors:  G S Giebink; C T Le; G Schiffman
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

7.  Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.

Authors:  Elliott Vichinsky; Zahra Pakbaz; Onyinye Onyekwere; John Porter; Paul Swerdlow; Thomas Coates; Peter Lane; Beatrice Files; Brigitta U Mueller; Lena Coïc; Gian Luca Forni; Roland Fischer; Peter Marks; Diana Rofail; Linda Abetz; Jean-Francois Baladi
Journal:  Acta Haematol       Date:  2008-04-11       Impact factor: 2.195

Review 8.  Sickle cell disease and infection.

Authors:  J K Onwubalili
Journal:  J Infect       Date:  1983-07       Impact factor: 6.072

Review 9.  Hypercoagulability in sickle cell disease: a curious paradox.

Authors:  Kenneth I Ataga; Eugene P Orringer
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965

View more
  6 in total

1.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

2.  Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial.

Authors:  M Beth McCarville; Zhaoyu Luo; Xiangke Huang; Renee C Rees; Zora R Rogers; Scott T Miller; Bruce Thompson; Ram Kalpatthi; Winfred C Wang
Journal:  AJR Am J Roentgenol       Date:  2011-06       Impact factor: 3.959

3.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.

Authors:  Steven M Szczepanek; Jeffrey T McNamara; Eric R Secor; Prabitha Natarajan; Linda A Guernsey; Lauren A Miller; Enrique Ballesteros; Evan Jellison; Roger S Thrall; Biree Andemariam
Journal:  Am J Pathol       Date:  2012-09-19       Impact factor: 4.307

5.  Clonal structure of Staphylococcus aureus colonizing children with sickle cell anaemia and healthy controls.

Authors:  F Schaumburg; B Biallas; A S Alabi; M P Grobusch; E N Feugap; B Lell; A Mellmann; G Peters; P G Kremsner; K Becker; A A Adegnika
Journal:  Epidemiol Infect       Date:  2012-10-10       Impact factor: 4.434

6.  The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria.

Authors:  Aurélie Laroque; Gundula Min-Oo; Mifong Tam; Prem Ponka; Mary M Stevenson; Philippe Gros
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.